California-based real-world information platform Atropos Health introduced that healthcare information analytics firm Arcadia has joined its well being portfolio, giving Arcadia’s supplier prospects and life sciences customers entry to Atropos’ choices.
Atropos Well being presents AI improvements, proof technology, analytics augmentation and information analysis to assist physicians entry real-world proof to information scientific choices and analysis.
The corporate’s scientific informatics companies, often called Inexperienced Button, present publication-grade observational research studies based mostly on a consumer’s scientific questions, and its providing Geneva OS is an working system for fast healthcare proof throughout an enormous community of real-world information.
Boston-based Arcadia is a healthcare information platform that offers suppliers instruments for community administration, managing funds, bettering processes relating to go to entry and referrals, and overseeing preauthorization.
By the partnership, Arcadia joins Atropos’ Proof Community, giving its customers entry to Atropos’ portfolio of purposes to help scientific decision-making in value-based care.
Atropos’ life sciences customers also can make the most of Arcadia’s longitudinal analysis dataset to conduct real-world proof research.
“A essential part of value-based care is the optimization of scientific decision-making the place present printed proof falls brief,” Dr. Brigham Hyde, CEO and cofounder of Atropos Well being, mentioned in a press release.
“This collaboration additional allows healthcare suppliers to generate novel peer-reviewed proof quickly to make data-driven choices on optimum scientific pointers, care pathways and the very best interventions to reach value-based care and different high quality initiatives.”
THE LARGER TREND
In December, GuideHealth, an AI-enabled value-based care supplier for well being methods, announced it had acquired Arcadia’s value-based care companies division and managed companies group.
The corporate additionally signed an settlement with Arcadia to make the most of its information analytics platform to energy the acquired choices, which can work with its predictive and generative AI.
In April, Arcadia scored $125 million in funding three years after receiving a $29.5 million progress fairness funding.
Final yr, Atropos Well being raised $14 million in Series A funding.
The corporate introduced quite a few partnerships final yr, together with collaborating with Janssen Analysis & Growth, a Johnson & Johnson firm, to speed up scientific improvement with real-world information evaluation.
Atropos additionally partnered with scientific analytics and affected person chart summarization firm KAID Well being, information sharing know-how startup Datavant and healthcare information firm SEQSTER.
